
China SXT Pharmaceuticals SXTC
$ 1.5
-2.02%
Annual report 2025
added 12-13-2025
China SXT Pharmaceuticals Depreciation & Amortization 2011-2025 | SXTC
Annual Depreciation & Amortization China SXT Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.3 K | 203 K | 250 K | 320 K | 345 K | 332 K | 181 K | 129 K | 94.4 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 345 K | 82.3 K | 215 K |
Depreciation & Amortization of other stocks in the Biotechnology industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
1.4 M | $ 4.75 | -0.84 % | $ 788 M | ||
|
Aclaris Therapeutics
ACRS
|
807 K | $ 3.02 | -0.66 % | $ 233 M | ||
|
Aeglea BioTherapeutics
AGLE
|
744 K | - | - | $ 1.01 B | ||
|
Alpine Immune Sciences
ALPN
|
597 K | - | - | $ 2.17 B | ||
|
AlloVir
ALVR
|
398 K | - | 4.14 % | $ 49.1 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
14 K | $ 0.22 | 23.66 % | $ 479 M | ||
|
Aptorum Group Limited
APM
|
1.13 M | $ 1.16 | -1.28 % | $ 6.33 M | ||
|
Ampio Pharmaceuticals
AMPE
|
122 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
3.13 M | - | - | $ 10.1 M | ||
|
Celldex Therapeutics
CLDX
|
3.18 M | $ 26.17 | -2.46 % | $ 1.69 M | ||
|
Aptevo Therapeutics
APVO
|
352 K | $ 0.56 | -40.06 % | $ 155 K | ||
|
Cellectar Biosciences
CLRB
|
192 K | $ 2.6 | -5.8 % | $ 31.8 M | ||
|
BioVie
BIVI
|
229 K | $ 1.18 | -7.48 % | $ 1.74 M | ||
|
Athersys
ATHX
|
1.43 M | - | 3.77 % | $ 22.4 M | ||
|
ARCA biopharma
ABIO
|
27 K | - | 1052.0 % | $ 415 M | ||
|
AVROBIO
AVRO
|
617 K | - | 1083.1 % | $ 745 M | ||
|
Acasti Pharma
ACST
|
7 K | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
9.45 M | - | -15.15 % | $ 60.3 M | ||
|
BioDelivery Sciences International
BDSI
|
140 K | - | -4.8 % | $ 255 M | ||
|
Albireo Pharma
ALBO
|
274 K | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.2 M | $ 26.92 | 0.41 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
172 M | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
6.43 M | $ 9.49 | 0.13 % | $ 139 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
11 K | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
9 M | - | -7.31 % | $ 87 M | ||
|
bluebird bio
BLUE
|
28 M | - | - | $ 546 M | ||
|
Dynavax Technologies Corporation
DVAX
|
4.63 M | $ 15.4 | 0.1 % | $ 2 B | ||
|
Arena Pharmaceuticals
ARNA
|
3.87 M | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
66 K | - | 2.71 % | $ 14 M | ||
|
Calithera Biosciences
CALA
|
300 K | - | -10.95 % | $ 876 K | ||
|
Axon Enterprise
AXON
|
48.4 M | $ 586.59 | -0.77 % | $ 44.4 B | ||
|
Ayala Pharmaceuticals
AYLA
|
162 K | - | - | $ 7.46 M | ||
|
Eton Pharmaceuticals
ETON
|
901 K | $ 16.76 | -1.38 % | $ 430 M | ||
|
Aytu BioScience
AYTU
|
5.38 M | $ 2.47 | -2.37 % | $ 15.5 M | ||
|
Exelixis
EXEL
|
28.8 M | $ 46.5 | -0.03 % | $ 13.5 B | ||
|
Foghorn Therapeutics
FHTX
|
3.12 M | $ 5.38 | -0.37 % | $ 295 M | ||
|
Acorda Therapeutics
ACOR
|
31.7 M | - | -24.86 % | $ 820 K | ||
|
Catalyst Biosciences
CBIO
|
1.07 M | $ 12.48 | 0.89 % | $ 822 M |